Cornerstone Therapeutics Inc. Stockholders Seeking More Money Regarding the Proposed Buyout by Chiesi Farmaceutici S.P.A. Encouraged to Contact Lawyers at Deans & Lyons PR Newswire DALLAS, Oct. 18, 2013 DALLAS, Oct. 18, 2013 /PRNewswire/ --Securities lawyers at Deans & Lyons announced a class action against the board of Cornerstone Therapeutics Inc. (NASDAQ: CRTX) in connection with a buyout for $9.50 per share. ConcernedCRTX investors should contact attorney Hamilton Lindley at 877-819-8033 or email@example.com about their rights and remedies. "Chiesi Farmaceutici has been a controlling shareholder since 2009 and currently owns 58% of Cornerstone stock. Yahoo! Finance has valued Cornerstone above the deal price consistently for the past month," said securities lawyer Hamilton Lindley. "Our potential shareholder lawsuit will seek to ensure that all relevant information is disclosed and that the Cornerstone Therapeutics Inc. shareholders receive the highest price reasonably available for their stock." Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide. CRTX stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at firstname.lastname@example.org or 877-819-8033 with questions or concerns. Hamilton Lindley DEANS & LYONS LLP 325 North Saint Paul Street, Suite 1500 Dallas, TX 75201 Phone: 214-736-7861 Fax: 214-965-8505 Toll-free: 877-819-8033 email@example.com www.deanslyons.com SOURCE Deans & Lyons, LLP Website: http://www.deanslyons.com
Cornerstone Therapeutics Inc. Stockholders Seeking More Money Regarding the Proposed Buyout by Chiesi Farmaceutici S.P.A.
Press spacebar to pause and continue. Press esc to stop.